Bradley Curtis

1.4k total citations
63 papers, 1.1k citations indexed

About

Bradley Curtis is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Bradley Curtis has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Economics and Econometrics and 8 papers in Epidemiology. Recurrent topics in Bradley Curtis's work include Diabetes Management and Research (37 papers), Diabetes Treatment and Management (31 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Bradley Curtis is often cited by papers focused on Diabetes Management and Research (37 papers), Diabetes Treatment and Management (31 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Bradley Curtis collaborates with scholars based in United States, United Kingdom and Australia. Bradley Curtis's co-authors include Kristina S. Boye, Julie Keeble, Fiona A. Russell, Anna Starr, Erika Pintér, Susan D. Brain, Dingfeng Jiang, William H. Shrank, Peter A. Cistulli and Barbara M. Taylor and has published in prestigious journals such as Diabetes, Cochrane Database of Systematic Reviews and Journal of Advanced Nursing.

In The Last Decade

Bradley Curtis

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bradley Curtis United States 19 579 164 145 125 120 63 1.1k
Abdulla O.A.A. Al-Hamaq Qatar 17 617 1.1× 275 1.7× 150 1.0× 67 0.5× 249 2.1× 32 1.3k
Craig Wood United States 15 90 0.2× 222 1.4× 69 0.5× 91 0.7× 85 0.7× 23 859
Priya M. John United States 14 831 1.4× 149 0.9× 244 1.7× 93 0.7× 211 1.8× 23 1.3k
Pearl Lee United States 13 256 0.4× 131 0.8× 68 0.5× 108 0.9× 137 1.1× 33 838
Joel Rodríguez‐Saldaña Mexico 10 522 0.9× 119 0.7× 56 0.4× 209 1.7× 260 2.2× 21 891
P. Passera Italy 18 865 1.5× 112 0.7× 67 0.5× 286 2.3× 497 4.1× 26 1.5k
S. J. J. Logtenberg Netherlands 19 424 0.7× 68 0.4× 223 1.5× 30 0.2× 106 0.9× 55 875
Gang-Jee Ko Hong Kong 11 232 0.4× 223 1.4× 58 0.4× 81 0.6× 138 1.1× 21 947
Benjumin Hsu Australia 19 295 0.5× 239 1.5× 56 0.4× 54 0.4× 50 0.4× 41 856
Ali Shahrami Iran 13 134 0.2× 53 0.3× 88 0.6× 68 0.5× 84 0.7× 42 658

Countries citing papers authored by Bradley Curtis

Since Specialization
Citations

This map shows the geographic impact of Bradley Curtis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley Curtis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley Curtis more than expected).

Fields of papers citing papers by Bradley Curtis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley Curtis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley Curtis. The network helps show where Bradley Curtis may publish in the future.

Co-authorship network of co-authors of Bradley Curtis

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley Curtis. A scholar is included among the top collaborators of Bradley Curtis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley Curtis. Bradley Curtis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srulovici, Einav, Maya Leventer‐Roberts, Bradley Curtis, et al.. (2020). Long‐term effectiveness of the Diabetes Conversation Map™ Program on health outcomes: A case–control retrospective cohort study. Journal of Advanced Nursing. 76(9). 2299–2310. 3 indexed citations
2.
Srulovici, Einav, Maya Leventer‐Roberts, Bradley Curtis, et al.. (2019). Effectiveness of Managing Diabetes During Ramadan Conversation Map intervention: A difference-in-differences (self-comparison) design. International Journal of Nursing Studies. 95. 65–72. 6 indexed citations
3.
Ray, Kausik K., David M. Kendall, Zhenxiang Zhao, et al.. (2018). A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy. Diabetes Obesity and Metabolism. 21(5). 1101–1110. 7 indexed citations
4.
Srulovici, Einav, Becca Feldman, Orna Reges, et al.. (2018). Which patients with Type 2 diabetes will have greater compliance to participation in the Diabetes Conversation Map™ program? A retrospective cohort study. Diabetes Research and Clinical Practice. 143. 337–347. 3 indexed citations
5.
Cushman, Daniel M., et al.. (2017). Does Trainee Involvement in Fluoroscopic Injections Affect Fluoroscopic Time, Immediate Pain Reduction, and Complication Rate?. PM&R. 9(10). 1013–1019. 6 indexed citations
6.
Brunt, Kate Van, Bradley Curtis, T. Iványi, et al.. (2016). Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin. Diabetes Therapy. 7(4). 793–807. 4 indexed citations
7.
Curtis, Bradley, Sarah L. Hulin-Curtis, Daniel R. Murphy, et al.. (2016). Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective. Journal of Medical Economics. 19(6). 549–556. 1 indexed citations
8.
Cushman, Daniel M., et al.. (2016). The effect of body mass index on fluoroscopic time and radiation dose during lumbar transforaminal epidural steroid injections. The Spine Journal. 16(7). 876–883. 16 indexed citations
9.
Eby, Elizabeth L., et al.. (2015). Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States. Clinical Therapeutics. 37(10). 2297–2308.e1. 7 indexed citations
10.
Boye, Kristina S., et al.. (2015). A model of mild hypoglycemia. Current Medical Research and Opinion. 31(4). 633–641. 7 indexed citations
11.
Eby, Elizabeth L., Anthony J. Zagar, Ping Wang, et al.. (2014). Healthcare Costs and Adherence Associated with Human Regular U-500 Versus High-Dose U-100 Insulin in Patients with Diabets. Endocrine Practice. 20(7). 663–670. 24 indexed citations
12.
Fu, Haoda, Bradley Curtis, Dara P. Schuster, Andreas Festa, & David M. Kendall. (2014). Treatment Patterns Among Older Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study. Diabetes Technology & Therapeutics. 16(12). 833–839. 5 indexed citations
13.
14.
Fu, Haoda, Bradley Curtis, Wenting Xie, et al.. (2014). Frequency and causes of hospitalization in older compared to younger adults with type 2 diabetes in the United States: A retrospective, claims-based analysis. Journal of Diabetes and its Complications. 28(4). 477–481. 14 indexed citations
15.
Eby, Elizabeth L., Ping Wang, Bradley Curtis, et al.. (2013). Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis. Journal of Medical Economics. 16(4). 529–538. 26 indexed citations
16.
Polinski, Jennifer M., et al.. (2013). Patterns and trends in insulin intensification among patients with type 2 diabetes: A systematic review. Primary care diabetes. 8(2). 101–109. 15 indexed citations
17.
18.
Pollock, Richard F., Bradley Curtis, Jayne Smith‐Palmer, & William J. Valentine. (2012). A UK Analysis of the Cost-Effectiveness of Humalog Mix75/25 and Mix50/50 Versus Long-Acting Basal Insulin. Advances in Therapy. 29(12). 1051–1066. 4 indexed citations
19.
Polinski, Jennifer M., Bradley Curtis, John D. Seeger, et al.. (2012). Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study. BMC Endocrine Disorders. 12(1). 20–20. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdulla O.A.A. Al-Hamaq Breakdown of academic impact, for papers by Craig Wood Breakdown of academic impact, for papers by Priya M. John Breakdown of academic impact, for papers by Pearl Lee Breakdown of academic impact, for papers by Joel Rodríguez‐Saldaña Breakdown of academic impact, for papers by P. Passera Breakdown of academic impact, for papers by S. J. J. Logtenberg Breakdown of academic impact, for papers by Gang-Jee Ko Breakdown of academic impact, for papers by Benjumin Hsu Breakdown of academic impact, for papers by Ali Shahrami
Rankless by CCL
2026